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Summary
Nicotinic acid adenine dinucleotide phosphate
(NAADP, 1) is the most potent intracellular Ca2+ mobi-
lizing agent in important mammalian cells and tissues,
yet the identity of the NAADP receptor is elusive. Sig-
nificantly, the coenzyme NADP is completely inactive
in this respect. Current studies are restricted by the
paucity of any chemical probes beyond NAADP itself,
and importantly, none is cell permeant. We report
simple nicotinic acid-derived pyridinium analogs as
low molecular weight compounds that (1) inhibit Ca2+
release via the NAADP receptor (IC50 w15mM – 1
mM), (2) compete with NAADP binding, (3) cross the
cell membrane of sea urchin eggs to inhibit NAADP-
evoked Ca2+ release, and (4) selectively ablate
NAADP-dependent Ca2+ oscillations induced by the
external gastric peptide hormone agonist cholecysto-
kinin (CCK) in murine pancreatic acinar cells.
Introduction
Ca2+ signals govern many global aspects of the cell,
while their shape in time and space is orchestrated by
mixing between separate stores [1]. Each of these is ad-
dressed by specific small molecules called second mes-
sengers that are produced within cells in response to
external stimuli [2, 3]. Cyclic adenosine dinucleotide
phosphate ribose (cADPR) and inositol 1,4,5-triphos-
phate (IP3) and their respective targets, the ryanodine
(RYR) and IP3 receptors (IP3R), are well known exam-
ples. Studies involving microinjection of NAADP, or pho-
toactivation of its caged derivative [4], have shown that
NAADP plays a key role in cholecystokinin- [5], but not
*Correspondence: james.dowden@nottingham.ac.ukbombesin- [6] or cholinergic- [7], mediated Ca2+ signal-
ing in pancreatic acinar cells. In pancreatic b cells, glu-
cose-, but not acetylcholine-, mediated signals are
affected, and here endogenous levels of NAADP have
been shown to increase in response to the glucose stim-
ulus, confirming its role as a second messenger [2, 8, 9].
NAADP has also been implicated in the regulation of
Ca2+ signaling in other cell types, including T cells [10],
heart myocytes [11], and neurons [12–14], yet little is
known about the biological machinery with which this
endogenous compound interacts.
Interestingly, the concentration-response relationship
for NAADP is bell-shaped in intact mammalian cells;
Ca2+ release is observed at nanomolar concentrations
of NAADP, but a thousand-fold increase in its concen-
tration causes no release and completely inactivates
the store [5, 9, 10]. This autoinhibitory effect has been
central to the characterization of this Ca2+ release mech-
anism so far.
The location of the NAADP store has to date been re-
fined to an acidic, lysosome-related organelle discrete
from the IP3R and RYRs that are located at the endo-
plasmic reticulum [15, 16]. These findings are conten-
tious, however; for example, one alternative model pro-
poses that NAADP directly interacts with RYRs [17]. The
absence of selective, cell-permeant chemical tools that
interact at the NAADP receptor has so far restricted in-
vestigations. Various L-type Ca2+ channel blockers (dil-
tiazem and dihydropyridines) and potassium channel
blockers (tetrahexylammonium [THA]) selectively inhibit
NAADP-induced release but, crucially, do not compete
with [32P]NAADP for binding at the receptor [18]. Tri-
azine dyes, in particular reactive red 120 (RR120), were
reported to reversibly bind to the NAADP receptor
(IC50 1.4 mM) and mobilize Ca
2+ at high concentrations
(100 mM) [19]. These compounds are not cell permeant,
however, and lack selectivity because they also interact
with IP3 receptors. Work on full-scale NAADP analogs
confirmed that display of a negative charge at the pyri-
dine 3 position was essential for activity; for example,
NADP and its 3-hydroxymethylpyridinium and 4-carboxy-
pyridinium variants are all inactive, whereas the 3-sul-
fonic acid derivative induced Ca2+ release, albeit with
reduced potency [20]. Later experiments confirmed the
importance of this part of the molecule for both binding
affinity and Ca2+ release, leading the authors to con-
clude that rational design of potential antagonists
should initially focus on mimicking other parts of the
second messenger [21]. This range of analogs is, how-
ever, largely constrained to those available from base-
exchange facilitated by ADP-ribosyl cyclases/NAD gly-
cohydrolases (E.C.3.2.2.5) [22, 23]. We recently reported
a flexible route to NAADP via total synthesis of NADP
that will offer a wider scope for structural modulation
of the whole messenger (for detailed examination of
the chemical biology of NAADP), but the general utility
of such tools is likely to be limited by the cost and
practicability of synthesis [24]. Studies to investigate
rational design of small-molecule analogs were there-
fore initiated.
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We sought simple truncated analogs that retain the 3-
carboxy group and the charged pyridinum scaffold to
exploit the tight binding pocket envisaged to be respon-
sible for the remarkable selectivity observed at the re-
ceptor. Alkylation of nicotinic acid [25] provided rapid
access to a range of trial compounds for biological eval-
uation (Figure 1). Broken egg preparations of the sea
urchin Lytechinus pictus are an ideal model for com-
pound evaluation, showing Ca2+ release from separately
addressable Ca2+ release mechanisms and stores. The
egg homogenate comprises functional vesicles that fully
sequester Ca2+ in ATP-supplemented buffer and then
release Ca2+ from discrete stores upon stimulus with
second messengers [26]. Concentration-dependent
Ca2+ release can therefore be measured using an ap-
propriate reporter dye, such as Fluo-3, and a simple
cuvette-based fluorimetry assay.
NAADP-induced Ca2+ release in sea urchin egg
homogenate is strongly concentration dependent; 10–
250 nM concentrations of the dinucleotide typically
cause a rapid increase in fluorescence followed by sub-
sequent decay back to baseline as free Ca2+ is returned
to the stores. A unique and useful feature of the sea ur-
chin system is that treatment with subthreshold concen-
trations of NAADP (0.2 nM) prevents Ca2+ release upon
subsequent challenge with normally releasing concen-
trations of NAADP [27].
Alkyl pyridinium compounds were therefore evalu-
ated, initially at 1 mM, for their ability to interact with
each aspect of the NAADP-sensitive Ca2+ release mech-
anism, including release and inactivation. Most com-
pounds tested were derived by alkylation of nicotinic
acid using simple hydrophobic reagents such as benzyl
bromide or allyl bromide and proved to be inactive under
the test conditions. Notably, two of the compounds
appeared to modulate NAADP-induced Ca2+ release.Compound 2, obtained by reaction between nicotinic
acid and 6-(2-bromo-acetylamino)-hexanoic acid methyl
ester diminished the extent of NAADP-induced Ca2+ re-
lease without affecting subsequent challenge with IP3,
or cADPR (Figure 2B). Evaluation across a range of
concentrations revealed that this compound is not par-
ticularly potent, however, with an approximate IC50 of
around 500 mM (Figure 2C). That this pyridinium analog
is weakly competitive at the NAADP binding site was
confirmed when the ratio of bound and free NAADP
was measured after microfiltration of homogenate first
treated with 2 in the presence of 0.2 nM [32P]NAADP.
Under these conditions high micromolar concentrations
of the pyridinium compounds were able to significantly
reduce the specific binding of [32P]NAADP (0.2 nM)
(Figure 2D).
Figure 1. The Structure Of NAADP and Pyridinium Analogs 2 and 3Figure 2. The Effect Of Pyridinium 2 on
NAADP-Induced Ca2+ Release from Sea
Urchin Egg Homogenate
(A) NAADP, cADPR, and IP3 all induce Ca
2+
release from sea urchin egg homogenates.
Samples were diluted to 2.5% in GluIM in
the presence of regenerating system and
kept at 17ºC with agitation for 3 hr to facili-
tate Ca2+ uptake into stores. Ca2+ release
was determined by an increase of Fluo-3
fluorescence at 526 nm. Data are expressed
as released [Ca2+] as determined by fluores-
cence in arbitrary units. n = >3. RFU = rela-
tive fluorescence units. The effects of maxi-
mal concentrations of each of these agents
are shown.
(B) Pretreatment of sea urchin egg homoge-
nate with the pyridinium compound 2 (1 mM)
selectively inhibits NAADP (250 nM)-induced
calcium release but does not significantly af-
fect release evoked by either IP3 (10 mM) or
cADPR (1 mM).
(C) Concentration-dependence of inhibition
of NAADP-evoked Ca2+ release by pyridi-
nium 2.
(D) Effect of various concentrations of pyridi-
nium 2 on [32P]NAADP binding to egg mem-
branes.
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661A more simple acetamide-derived compound, 3,
proved to be a much more potent modulator of
NAADP-induced Ca2+ release. A significant reduction
in the effect of 250 nM NAADP on Ca2+ release from
broken sea urchin egg preparations was observed in
Figure 3. Treatment of Sea Urchin Egg Homogenate with Pyridi-
nium 3 Substantially Reduces NAADP-Induced Ca2+ Release
(A) Normal effect of NAADP (250 nM) on Ca2+ release from egg
homogenates.
(B) Pyridinium compound 3 (30 mM) alone causes a small stable in-
crease in fluorescence. Subsequent addition of NAADP (250 nM) in-
duces a much reduced Ca2+ release compared to the control (A).the presence 30 mM pyridinium 3 (Figure 3B). Evaluation
across a range of concentrations suggested an approx-
imate IC50 of around 15 mM (Figure 4A). Notably, neither
unmodified nicotinic acid, nicotinic acid riboside, nor
the nicotinamide-derived compound 4 caused this ef-
fect (data not shown). At a 30 mM concentration of 3,
a small amount of Ca2+ release was observed at approx-
imately 15% of that induced by 250 nM NAADP. Plotting
the maximal Ca2+ release of the pyridinium compound 3
alone confirmed this result and indicated that higher
concentrations of the compound (>100 mM) appear to
cause moderate Ca2+ release from this store, suggest-
ing that the compound is a partial agonist. This effect
was reduced by pretreatment of egg homogenates
with a desensitizing concentration of NAADP (3 nM;
data not shown) [27]. Furthermore, the compound
does not affect Ca2+ release from other stores controlled
either by cADPR or InsP3 (Figure 4B).
Total specific binding of [32P]NAADP (Bmax) was re-
duced from 69% 6 3% to 46% 6 3% (n = 3) in the pres-
ence of 10 mM acetamide-derived pyridinium 3, but was
not affected at lower concentrations of the small-mole-
cule analog (1 and 100 nM) (Figure 4C). The compound
was weakly competitive with [32P]NAADP binding to
egg membranes with an IC50 of around 90mM (Figure 4D).
Single-cell studies on intact sea urchin eggs using
confocal microscopy, the reporter dye Ca2+ green dex-
tran, and photoactivation of caged NAADP showed
that, despite their polar character, the compounds
were indeed cell permeant and clearly selective for the
NAADP receptor within these cells. Brief UV laser flash
photolysis (351 and 364 nm) induced the characteristic
Ca2+ transient in untreated eggs (Figure 5A), but not
in those first incubated with pyridinium 3 (10 mM) in ex-
tracellular sea water buffer (Figure 5B). In contrast, otherFigure 4. Effects of Varied Concentrations of
Nicotinic Acid Derivative 3 on NAADP-Medi-
ated Ca2+ Mobilization and Binding
(A) Compound 3 inhibits NAADP-mediated
Ca2+ release in sea urchin egg homogenate
with an apparent IC50 of around 15 mM.
Data are expressed as percentage of Ca2+
release induced by 250 nM NAADP alone,
and bars represent the mean 6 standard
error of the mean of three independent ex-
periments. Filled triangles indicate the per-
centage release induced by NAADP in the
presence of pyridinium 3. Filled squares indi-
cate the effect of 3 alone. At concentrations
greater than 100 mM, the compound induces
a Ca2+ release itself.
(B) Pyridinium 3 is selective because it in-
hibits Ca2+ release induced by NAADP, but
has little effect on Ca2+ release in sea urchin
egg homogenate induced by maximal con-
centrations of cADPR and IP3. Data are
expressed as percentage of Ca2+ release in-
duced by NAADP, cADPR, or IP3 in the ab-
sence of 3, and bars represent the mean 6
standard error of the mean of three indepen-
dent experiments.
(C) 10 mM pyridinium 3 reduces the Bmax
from 69% 6 3% to 46% 6 3%. Bars represent the mean 6 standard error of the mean of three independent experiments. Data are expressed
as percentage of total binding. Filled squares indicate specific binding of [32P]NAADP in the presence of increasing concentrations of NAADP;
filled diamonds indicate binding in the presence of 10 mM derivative 3.
(D) [32P]NAADP (0.2 nM) specific binding to egg membranes is reduced by 3 in a concentration-dependent manner with an approximate IC50 of
90 mM.
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662Figure 5. External Application of Pyridinium
3 Abolishes Ca2+ Release in Response to
Photolysis of Caged NAADP in Intact Sea
Urchin Eggs
Ca2+ is measured by the ratio of fluores-
cence observed for reporter dye, Ca2+ green
dextran, before and after photolysis plotted
against time (minutes).
(A) The normal response of an intact sea
urchin egg to photolytic activation of intra-
cellular caged NAADP.
(B) Extracellular compound 3 (10 mM) in sea
water buffer reduced this response.
(C) Nicotinamide applied at the same external concentration to sea water buffer has no effect on the initial NAADP response. The specificity of
extracellular application of the pyridinium 3 compound can thus be assessed by comparing it to the concentrations of other cell-permeant
molecules. We used 10 mM, which is 300-fold higher than that required for half-maximal inhibition in the sea urchin egg homogenate. This
is comparable to similar experiments involving cell-permeant cAMP and cGMP (Bromo or diacetyl forms) that are typically added at extracel-
lular concentrations between 0.1 and 1 mM [31], 100–10,000 times higher concentration than that required to elicit a response in homogenized
preparations [32].analogs, including nicotinamide, did not abolish NAADP-
evoked Ca2+ release (Figure 5C). The notable absence of
second-phase Ca2+ release in the nictonamide-treated
cells may reflect the established role of cADPR in medi-
ating the prolongation of the calcium signal in sea urchin
eggs, as also observed at fertilization [28, 29].
These promising results encouraged examination of
the compound in mammalian cells. Pancreatic acinar
cells have been widely used for research into agonist-
specific Ca2+ signaling. Control of fluid secretion, exocy-
tosis, and trophic effects are controlled by Ca2+ signals
of subtly different shape depending on whether they are
induced by gastrointestinal peptides, such as cholecys-
tokinin (CCK) and bombesin, or the neurotransmitter
acetylcholine. Addition of CCK induces characteristic
Ca2+ oscillations that cannot be recreated by combina-
tion of InsP3 or cADPR [3] and that, in contrast to bomb-
esin and acetylcholine, are linked to NAADP production
[30]. Administration of low concentrations of NAADP to
these cells effectively reproduces the same signals as
CCK, while high concentrations selectively inhibit these
signals as a result of the distinctive autoinactivation
properties described earlier [5].
Normally, CCK-induced Ca2+ oscillations persist for
several minutes for as long as pancreatic acinar cells
are exposed to the peptide [5, 30]. Most significantly,
addition of the acetamide derivative 3 to the extracellu-
lar milieu significantly attenuated CCK-induced signals,
provoking a decrease in the frequency and amplitude of
the oscillations, which quickly retreated to baseline (Fig-
ure 6A). In the complementary experiment, CCK failed to
stimulate more than weak, irregular signals in cells that
had first been treated with the same small-molecule
modulator (Figure 6B). In contrast, the effects of extra-
cellular pyridinium 3 on acetylcholine-evoked Ca2+ re-
sponses were much less pronounced, consistent with
an absence of a role for NAADP in mediating the cal-
cium-mobilizing effects of this agonist [7] (Figure 6C).
These data highlight simple pyridinium compounds as
the first cell-permeant small molecules that modulate
NAADP-evoked Ca2+ mobilization in both mammalian
pancreatic acinar cells and in intact sea urchin eggs.
These compounds are designed to exploit the appar-
ently very strong discrimination between NADP and
NAADP observed in all known NAADP-responsive cells,
which presumably arises from a tight, specific carboxy-anion binding pocket local to the as yet uncharacter-
ized receptor. Alternative models, such as binding at
an allosteric regulation site, cannot be ruled out and
will require detailed characterization of the NAADP re-
ceptor. The simple synthetic route toward these proto-
typical compounds should ensure their general utility
to the community. Meanwhile, their low molecular
weight also encourages further investigation and opti-
mization of the chemical space around this structure.
More potent compounds that target the nicotinic acid
binding pocket of the NAADP receptor will explore the
idea that these compounds will be agonists [21]; our
Figure 6. CCK-Induced Ca2+ Oscillations in Murine Pancreatic
Acinar Cells Are Reduced or Inhibited by External Application of 3
Ratio of fluorescence emitted at 510 nm, upon alternate excitation
at 340/380 nm, by fura2-AM (a Ca2+-dependent fluorophore) plot-
ted against time. Scale bars represent 100 s.
(A) External addition of 3 (1 mM) leads to oscillations of reduced
frequency and magnitude that decay to zero.
(B) Cells first incubated with 3 (1 mM) and then treated with CCK
(5 pM) show very weak Ca2+ oscillations with greatly reduced fre-
quency.
(C) In contrast the effects on CCK-mediated Ca2+ spikes, the re-
sponse to acetylcholine (50 nM) after extracellular application of 3
(1 mM) persists with little change.
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663earlier observation that acetamide-derived compound 3
may be a partial agonist might support this idea. These
preliminary results outline an interesting new direction
for exploration of the chemistry of the NAADP receptor,
although an expansion of the repertoire of molecules un-
der evaluation will be required to develop the insight
necessary to improve their potency. More detailed stud-
ies of the structure-activity relationships for these and
related structures are underway. Elaborated scaffolds
with fluorescent or affinity functionality that may facili-
tate assay, facilitate localization, or indeed assist in the
purification of the biological target for NAADP are also
in preparation. Additionally, the combination of modula-
tor and target may provide the basis for the develop-
ment of potential novel therapeutic strategies, and we
are currently extending functional studies to other sig-
nificant cell types.
Significance
We report small-molecule pyridinium compounds de-
signed to mimic the nicotinic acid portion of NAADP.
In the absence of sequence or structural data, we ex-
ploited the significant selectivity for NAADP over
NADP that might arise from a tight binding subsite at
the putative receptor. Reaction between nicotinic acid
and alkyl halides provided a small array of pyridinium
compounds that were evaluated for their effect onCa2+
release in fresh sea urchin egg homogenate. Two ana-
logs emerged from these studies that diminished Ca2+
release induced byNAADPbut not by the other second
messengers cADPR and IP3, the most potent of which
(IC50w15 mM) was derived from reaction with bromoa-
cetamide. At >10 mM concentration, this pyridinium li-
gand was competitive at the NAADP binding site and
reduced the total specific binding of [32P]NAADP
(Bmax) from 69%6 3% to 46%6 3% (n = 3). Penetration
of the cell membrane was demonstrated in intact sea
urchin eggs, where exogenous application of the com-
pound abolished transient Ca2+ release induced by
photolysis of caged NAADP. In murine pancreatic aci-
nar cells, the frequency and amplitude of characteris-
tic Ca2+ oscillations induced by the gastrointestinal
agonist cholecystokinin (CCK) were decreased to
baseline upon external application of the pyridinium
analog, while cells first treated with the same com-
pound showed only weak Ca2+ oscillations with irreg-
ular frequency in response to CCK. Together, these re-
sults define the first cell-permeant modulator of
NAADP-induced Ca2+ release and are highly signifi-
cant because current investigations are restricted to
close relatives of NAADP that aremainly cell imperme-
ant and require additional techniques to bypass the
cell membrane.We anticipate that the relatively simple
low molecular weight scaffold reported herein can
be easily developed as more effective molecular
probes of the intracellular chemistry and biology of
NAADP and potentially even as new therapeutics.
Experimental Procedures
Chemistry: General
NMR spectra were recorded using JEOL JMN GX-270 or Bruker AV-
400 spectrometer for 1H (270 or 400 MHz) and 13C (75 or 100 MHz).Chemical shifts (d) are given in ppm relative to residual solvent
peaks, and coupling constants (J values) are in Hertz. Mass spectra
data were collected on a Micromass LCT mass spectrometer sys-
tem using electrospray ionization (ESI).
General Procedure
All reagents and solvents were from commercial suppliers and used
as supplied. A solution of nicotinic acid (100 mg, 0.81 mmol) and the
appropriate alkyl halide (0.81 mmol) was heated in DMF at 50ºC for
10 hr, and then concentrated, suspended in CH3OH, and precipi-
tated by addition of ethyl acetate.
1-Carbamoylmethyl-3-Carboxy-Pyridinium Iodide 3
Reaction with 2-iodoacetamide (150 mg, 0.812 mmol) provided the
compound as a yellow amorphous solid (175 mg, 70%) mp:
223ºC–225ºC; 1H-NMR (270 MHz, D2O): d 9.24 (s, 1H), 9.0 (d, J 8.2,
1H), 8.89 (d, J 4.8, 1H), 8.17 (m, 1H) and 5.56 (2H, s); 13C-NMR (75
MHz, D2O): d 169.5, 167.3, 149.3, 148.6, 148.1, 135.6, 129.5, 63.2.
IR (KBr) 3379, 1701, 1665 cm21. HRMS (m/z): [M]2 calcd for
C8H7N2O3 179.0457; found, 179.0491 (100%), [2MH]
2 calcd for
C16H15N4O6 359.09912; found, 359.1024 (90%) [25].
3-Carboxy-1-[(5-Methoxycarbonyl-Pentylcarbamoyl)-Methyl]-
Pyridinium Bromide 2
Reaction with 6-(2-bromo-acetylamino)-hexanoic acid methyl ester
(550 mg, 2.18 mmol) and nicotinic acid (269 mg, 2.18 mmol) yielded
a beige amorphous solid (250 mg, 30%) 1H-NMR (400 MHz, D2O):
9.29 (s, 1H), 9.05 (d, J 7.9, 1H), 8.93 (d, J 6.2, 1H), 8.22–8.19 (dd, J
7.9, 6.2,1H), 5.22 (s, 2H), 3.66 (s, 3H), 3.29 (t, J 6.8, 2H), 2.40–2.35
(m 2H), 1.66–1.49 (m, 4H) and 1.38–1.29 (m, 2H). dC (100 MHz, D2O)
177.5, 165.3, 165.2, 147.8, 146.9, 146.6, 134.5, 128.0, 61.9, 52.1,
39.7, 33.5, 27.7, 25.4 and 23.8. m/z [FAB+] 309.1 (M+, 100%) HRMS
(m/z): [M]+ calcd for C15H21N2O5 309.1450; found, 309.1456.
Biological Evaluation
Sea Urchin Egg Homogenate Ca2+ Release Assay
Sea urchin egg homogenate was prepared and diluted to 2.5% in
GluIM consisting of 250 mM potassium gluconate, 250 mM N-meth-
ylglucamine, 20 mM HEPES (pH 7.2), 1 mM MgCl2, 1.0 mM ATP,
10 mM phosphocreatine, 10 units/ml creatine phosphokinase,
1 mM sodium azide, and 3 mM fluo-3 in the presence of regenerating
system and kept at 17ºC with agitation for 3 hr to facilitate Ca2+
uptake into stores. Ca2+ release was determined by measuring the
increase in Fluo-3 fluorescence at 526 nm.
[32P]NAADP Binding to 0.5% Sea Urchin Egg Homogenate
[32P]NAADP was obtained as described [33]. Dilute homogenate (as
above) was preincubated with acetamide derivative 3 for 10 min, and
then 0.2 nM [32P]NAADP was added and the mixture was incubated
at room temperature for a further 15 min. Samples were filtered
through Whatman GF/B filters to separate bound and free
[32P]NAADP ligand [34].
Intact Sea Urchin Eggs
Sea urchin eggs were microinjected with a solution containing the
Ca2+ reporter dye, Ca2+ green dextran, and caged NAADP [4] and
incubated in sea water containing the test pyridinium compound 3
(10 mM). Fluorescence intensity was imaged using a Leica confocal
microscope using an excitation wavelength of 488 nm.
Sea urchin eggs of Lytechinus pictus were obtained by intracoelo-
mic injection of 0.5 M KCl shed into artificial sea water (435 mM NaCl,
40 mM MgCl2, 15 mM MgSO4, 11 mM CaCl2, 10 mM KCl, 2.5 mM
NaHCO3, 1 mM EDTA), dejellied by passing through a 90 mm nylon
mesh, and then washed twice by centrifugation. Eggs were trans-
ferred to polylysine-coated glass coverslips for microinjection and
microscopy. Oregon green 488 BAPTA (1,2-bis(2-aminophenoxy)-
ethane-N,N,N0,N0-tetraacetic acid dextran; Molecular Probes) was
pressure-microinjected (Picospritzer; World Precision Instruments).
The Ca2+-sensitive dye was imaged by laser-scanning confocal mi-
croscopy (Leica model TCS NT) using the 488 nm line of an argon ion
laser for excitation, and the emission was long pass-filtered (515 nm)
and detected with a photomultiplier tube. Caged NAADP (29P-(1-(2-
nitrophenyl)ethyl) NAADP; Molecular Probes) was purified further by
high-performance liquid chromatography to remove small amounts
of contaminating free NAADP. Caged NAADP was photolyzed with
ultraviolet light (351 and 364 nm lines) from an argon ion laser
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664(Enterprise model 651; Coherent) that was directed into the scanning
head by a quartz fiber optic cable. The spatial location of photolysis
was controlled via a shutter that was placed in the light path of the
ultraviolet laser. This resulted in a band of UV across the image
with the position and width of the band being controllable. The con-
focal images were processed with the software NIH Image to create
a self ratio by dividing the intensity (F) of each image on a pixel-by-
pixel basis by the intensity of an image acquired before stimulation
(F0). Time courses of F/F0 are plotted against time.
Murine Pancreatic Acinar Cells
All experiments were conducted at room temperature. Pancreatic
acinar cells were isolated from mice, dispersed by collagen treat-
ment, and then seeded onto polylysine-coated number 1 glass cov-
erslips and loaded by incubating cells with 1–5 mM fura-2 acetoxy-
methylester (Molecular Probes; Leiden, Holland) for 60 min. The
cells were subsequently washed, maintained in buffer (140 mM
NaCl, 4.7 mM KCl, 1.1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES,
and 10 mM glucose [pH 7.2]) and used immediately. Compound 3
(1 mM) was added before or after Cholecystokinin (CCK; 5 pM) or
acetylcholine (ACh; 50 nM) was added, the cells were excited alter-
nately with 340 and 380 nm light (emission 510 nm), and the ratio of
the intensities of emitted light at the two excitation wavelengths
were recorded using a 12 bit CCD camera (MicroMax; Princeton
Instruments, NJ) and plotted against time.
Acknowledgments
This research was funded by the Biotechnology and Biology Sci-
ences Research Council. A.G. was a Wellcome Trust Senior Fellow
in Basic Biomedical Research. We acknowledge the use of the
EPSRC Chemical Database Service at Daresbury.
Received: November 1, 2005
Revised: April 11, 2006
Accepted: May 8, 2006
Published: June 23, 2006
References
1. Berridge, M.J., Lipp, P., and Bootman, M.D. (2000). The versatil-
ity and universality of calcium signaling. Nat. Rev. Mol. Cell Biol.
1, 11–21.
2. Yamasaki, M., Masgrau, R., Morgan, A.J., Churchill, G.C., Patel,
S., Ashcroft, S.J.H., and Galione, A. (2004). Organelle selection
determines agonist-specific Ca2+ signals in pancreatic acinar
and beta cells. J. Biol. Chem. 279, 7234–7240.
3. Cancela, J.M., Van Coppenolle, F., Galione, A., Tepikin, A.V., and
Petersen, O.H. (2002). Transformation of local Ca2+ spikes to
global Ca2+ transients: the combinatorial roles of multiple Ca2+
releasing messengers. EMBO J. 21, 909–919.
4. Lee, H.C., Aarhus, R., Gee, K.R., and Kestner, T. (1997). Caged
nicotinic acid adenine dinucleotide phosphate. Synthesis and
use. J. Biol. Chem. 272, 4172–4178.
5. Cancela, J.M., Churchill, G.C., and Galione, A. (1999). Coordina-
tion of agonist-induced Ca2+-signalling patterns by NAADP in
pancreatic acinar cells. Nature 398, 74–76.
6. Burdakov, D., and Galione, A. (2000). Two neuropeptides recruit
different messenger pathways to evoke Ca2+ signals in the same
cell. Curr. Biol. 10, 993–996.
7. Cancela, J.M., Gerasimenko, O.V., Gerasimenko, J.V., Tepikin,
A.V., and Petersen, O.H. (2000). Two different but converging
messenger pathways to intracellular Ca2+ release: the roles of
nicotinic acid adenine dinucleotide phosphate, cyclic ADP-
ribose and inositol trisphosphate. EMBO J. 19, 2549–2557.
8. Johnson, J.D., and Misler, S. (2002). Nicotinic acid-adenine di-
nucleotide phosphate-sensitive calcium stores initiate insulin
signaling in human beta cells. Proc. Natl. Acad. Sci. USA 99,
14566–14571.
9. Masgrau, R., Churchill, G.C., Morgan, A.J., Ashcroft, S.J.H., and
Galione, A. (2003). NAADP. A new second messenger for glu-
cose-induced Ca2+ Responses in clonal pancreatic beta cells.
Curr. Biol. 13, 247–251.
10. Berg, I., Potter, B.V.L., Mayr, G.W., and Guse, A.H. (2000). Nico-
tinic acid adenine dinucleotide phosphate (NAADP(+)) is anessential regulator of T-lymphocyte Ca2+-signaling. J. Cell
Biol. 150, 581–588.
11. Bak, J., Billington, R.A., Timar, G., Dutton, A.C., and Genazzani,
A.A. (2001). NAADP receptors are present and functional in the
heart. Curr. Biol. 11, 987–990.
12. Bak, J., White, P., Timar, G., Missiaen, L., Genazzani, A.A., and
Galione, A. (1999). Nicotinic acid adenine dinucleotide phos-
phate triggers Ca2+ release from brain microsomes. Curr. Biol.
9, 751–754.
13. Patel, S., Churchill, G.C., Sharp, T., and Galione, A. (2000). Wide-
spread distribution of binding sites for the novel Ca2+-mobilizing
messenger, nicotinic acid adenine dinucleotide phosphate, in
the brain. J. Biol. Chem. 275, 36495–36497.
14. Brailoiu, E., Hoard, J.L., Filipeanu, C.M., Brailoiu, G.C., Dun, S.L.,
Patel, S., and Dun, N.J. (2005). Nicotinic acid adenine dinucleo-
tide phosphate potentiates neurite outgrowth. J. Biol. Chem.
280, 5646–5650.
15. Lee, H.C., and Aarhus, R. (2000). Functional visualization of the
separate but interacting calcium stores sensitive to NAADP
and cyclic ADP-ribose. J. Cell Sci. 113, 4413–4420.
16. Churchill, G.C., Okada, Y., Thomas, J.M., Genazzani, A.A., Patel,
S., and Galione, A. (2002). NAADP mobilizes Ca2+ from reserve
granules, a lysosome-related organelle, in sea urchin eggs.
Cell 111, 703–708.
17. Gerasimenko, J.V., Maruyama, Y., Yano, K., Dolman, N.J., Tepi-
kin, A.V., Petersen, O.H., and Gerasimenko, O.V. (2003). NAADP
mobilizes Ca2+ from a thapsigargin-sensitive store in the nuclear
envelope by activating ryanodine receptors. J. Cell Biol. 163,
271–282.
18. Genazzani, A.A., Mezna, M., Dickey, D.M., Michelangeli, F., Wal-
seth, T.F., and Galione, A. (1997). Pharmacological properties of
the Ca2+-release mechanism sensitive to NAADP in the sea ur-
chin egg. Br. J. Pharmacol. 121, 1489–1495.
19. Billington, R.A., Bak, J., Martinez-Coscolla, A., Debidda, M., and
Genazzani, A.A. (2004). Triazine dyes are agonists of the NAADP
receptor. Br. J. Pharmacol. 142, 1241–1246.
20. Lee, H.C., and Aarhus, R. (1997). Structural determinants of
nicotinic acid adenine dinucleotide phosphate important for its
calcium-mobilizing activity. J. Biol. Chem. 272, 20378–20383.
21. Billington, R.A., Tron, G.C., Reichenbach, S., Sorba, G., and
Genazzani, A.A. (2005). Role of the nicotinic acid group in
NAADP receptor selectivity. Cell Calcium 37, 81–86.
22. Bernofsky, C. (1980). Nicotinic acid adenine dinucleotide phos-
phate (NAADP+). Methods Enzymol. 66, 105–112.
23. Chini, E.N., Chini, C.C., Kato, I., Takasawa, S., and Okamoto, H.
(2002). CD38 is the major enzyme responsible for synthesis of
nicotinic acid- adenine dinucleotide phosphate in mammalian
tissues. Biochem. J. 362, 125–130.
24. Dowden, J., Moreau, C., Brown, R.S., Berridge, G., Galione, A.,
and Potter, B.V.L. (2004). Chemical synthesis of the second
messenger nicotinic acid adenine dinucleotide phosphate by to-
tal synthesis of nicotinamide adenine dinucleotide phosphate.
Angew. Chem. Int. Ed. Engl. 43, 4637–4640.
25. Shubert, M.P. (1936). The interactions of iodoacetic acid and ter-
tiary amines. J. Biol. Chem. 116, 437–445.
26. Clapper, D.L., Walseth, T.F., Dargie, P.J., and Lee, H.C. (1987).
Pyridine nucleotide metabolites stimulate calcium release from
sea urchin egg microsomes desensitized to inositol trisphos-
phate. J. Biol. Chem. 262, 9561–9568.
27. Genazzani, A.A., Empson, R.M., and Galione, A. (1996). Unique
inactivation properties of NAADP-sensitive Ca2+ release.
J. Biol. Chem. 271, 11599–11602.
28. Churchill, G.C., and Galione, A. (2001). NAADP induces Ca2+ os-
cillations via a two-pool mechanism by priming IP3- and cADPR-
sensitive Ca2+ stores. EMBO J. 20, 2666–2671.
29. Sethi, J.K., Empson, R.M., and Galione, A. (1996). Nicotinamide
inhibits cyclic ADP-ribose-mediated calcium signalling in sea
urchin eggs. Biochem. J. 319, 613–617.
30. Yamasaki, M., Thomas, J.M., Churchill, G.C., Garnham, C.,
Lewis, A.M., Cancela, J.M., Patel, S., and Galione, A. (2005).
Role of NAADP and cADPR in the induction and maintenance
of agonist-evoked Ca2+ spiking in mouse pancreatic acinar cells.
Curr. Biol. 15, 874–878.
Small-Molecule Modulators of Ca2+ Release
66531. Schultz, C., Vajanaphanich, M., Harootunian, A.T., Sammak,
P.J., Barrett, K.E., and Tsien, R.Y. (1993). Acetoxymethyl Esters
of Phosphates, Enhancement of the Permeability and Potency
of cAMP. J. Biol. Chem. 268, 6316–6322.
32. Robinson, G.A., Butcher, R.W., Sutherland, E.W., Posternak, T.,
and Hardman, J.G. (1971). Cyclic AMP (New York: Academic
Press).
33. Galione, A., Cancela, J.M., Churchill, G.C., Genazzani, A.A., Lad,
C., Thomas, J.M., Wilson, H., and Terrar, D. (2000). Methods in
cyclic ADP-ribose and NAADP research. In Methods in Calcium
Signalling, J.J. Putney, ed. (Boca Raton, FL: CRC Press), pp.
249–296.
34. Patel, S., Churchill, G.C., and Galione, A. (2000). Unique kinetics
of nicotinic acid-adenine dinucleotide phosphate (NAADP) bind-
ing enhance the sensitivity of NAADP receptors for their ligand.
Biochem. J. 352, 725–729.
